Alloimmune thrombocytopenia

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 897-909

  Gyamfi, Cynthia ^a,b   Eddleman, Keith A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MATERNAL ANTIBODY; PREDNISONE;

ALLOIMMUNITY; ALLOIMMUNIZATION; AUTOIMMUNE THROMBOCYTOPENIA; CLINICAL FEATURE; HUMAN; IMMUNOASSAY; INCIDENCE; LABORATORY TEST; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY DISORDER; PRENATAL PERIOD; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DISEASES; HUMANS; ISOANTIBODIES; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOCYTOPENIA;

EID: 29544446158     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000184775.02793.45     Document Type: Review

References (49)

1. Blancette VS, Johnson J, Rand M. The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol. 2000;13:365-390.
2. von dem Borne AEG, Decary F, and ICSH/ISBT Working Party on Platelet Serology. Nomenclature of platelet-specific antigens. Vox Sang. 1990;58:176.
3. Rayment R, Brunskill SJ, Stanworth S, et al. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev. 2005;1:CD004226.
4. Bussel JB. Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost. 2001;27:245-252.
5. Murphy MF, Williamson LM. Antenatal screening for the fetomaternal alloimmune thrombocytopenia: an evaluation using the criteria of the UK national screening committee. Br J Haematol. 2000;111:726-732.
6. King KE, Kao KJ, Bray PF, et al. The role of HLA antibodies in neonatal thrombocytopenia: a prospective study. Tissue Antigens. 1996;47:206-211.
7. Chow MP, Sun KJ, Yung CH, et al. Neonatal alloimmune thrombocytopenia due to HLA-A2 antibody. Acta Haematol. 1992;88:217-218.
8. Sasaki M, Yagihashi A, Kobayashi D, et al. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report. Pediatr Hematol Oncol. 2001;18:519-524.
9. De Tar MW, Klohe E, Grosset A, et al. Neonatal alloimmune thrombocytopenia with HLA alloimmunization: case report with immunohematological and placental findings. Pediatr Dev Pathol. 2002;5:200-205.
10. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood. 1997;89:4402-4406.
11. Panzer S, Auerbach L, Cechova E, et al. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol. 1995;90:655-660.
12. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329:1463-1466.
13. de Moerloose P, Boehlen F, Extermann P, et al. Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay. Br J Haematol. 1998;100:735-740.
14. Sainio S, Jarvenpaa AL, Renlund M, et al. Thrombocytopenia in term infants: a population-based study. Obstet Gynecol. 2000;95:441-446.
15. Davoren A, McParland P, Crowley J, et al. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland. Br J Obstet Gynaecol. 2003;110:492-496.
16. Murphy MF, Williamson LM, Urbaniak SJ. Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sang. 2002;83:409-416.
17. L'Abbe D, Tremblay L, Goldman M, et al. Alloimmunization to platelet antigen HPA-1a (Zwa): association with HLA-DRw52a is not 100%. Transfus Med. 1992;2:251.
18. Skupski DW, Bussel JB. Alloimmune thrombocytopenia. Clin Obstet Gynecol. 1999;42:335-348.
19. Blanchette VS. Neonatal alloimmune thrombocytopenia. In: Stockman JA III, Pochedly C, eds. Developmental and Neonatal Hematology. New York: Raven Press; 1988:145-168.
20. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989;1:363-366.
21. Herman JH, Jumbelic MI, Ancona RJ, et al. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Pediatr Hematol Oncol. 1986;8:312-317.
22. Johnson JM, McFarland JG, Blanchette VS, et al. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using an allele-specific oligonucleotide probe. Prenat Diagn. 1993;13:1037-1042.
23. von dem Borne AE, Verheugt FW, Oosterhof F, et al. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol. 1978;39:195-207.
24. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987;70:1722-1726.
25. Nordhagen R, Flaathen ST. Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test. Vox Sang. 1985;48:156-159.
26. Karpatkin M, Porges RF, Karpatkin S. Platelet counts in infants of women with autoimmune thrombocytopenia: effect of steroid administration to the mother. N Engl J Med. 1981;305:936-939.
27. Daffos F, Forestier F, Muller JY, et al. Prenatal treatment of alloimmune thrombocytopenia. Lancet. 1984;2:632.
28. Newland AC, Boots MA, Patterson KG. intravenous IgG for autoimmune thrombocytopenia in pregnancy. N Engl J Med. 1984;310:261-262.
29. Derycke M, Dreyfus M, Ropert JC, et al. Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia. Arch Dis Child. 1985;60:667-669.
30. Bussel JB, Berkowitz RL, McFarland JG, et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med. 1988;319:1374-1378.
31. Lynch L, Bussel JB, McFarland JG, et al. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol. 1992;80:67-71.
32. Kanhai HH, Porcelijn L, van Zoeren D, et al. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families. Eur J Obstet Gynecol Reprod Biol. 1996;68:67-73.
33. Silver RM, Porter TF, Branch DW, et al. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol. 2000;182:1233-1238.
34. Radder CM, Kanhai HH, de Beaufort AJ, et al. Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage. Ned Tijdschr Geneeskd. 2000;144:2015-2018.
35. Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol. 2001;185:683-688.
36. Birchall JE, Murphy MF, Kaplan C, et al, for the European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of fetomaternal alloimmune thrombocytopenia. Br J Haematol. 2003;122:275-288.
37. Radder CM, de Haan MJJ, Brand A, et al. Follow up of children after antenatal treatment for alloimmune thrombocytopenia. Early Hum Dev. 2004;80:65-76.
38. Bussel JB, Berkowitz RL, Lynch L, et al. Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: a randomized trial of the addition of low-dose steroid to intravenous γ-globulin. Am J Obstet Gynecol. 1996;174:1414-1423.
39. Paidas MJ, Berkowitz RL, Lynch L, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol. 1995;172:475-479.
40. Engelfriet CP, Reesink HW, Kroll H, et al. Prenatal management of alloimmune thrombocytopenia of the fetus. Vox Sang. 2003;84:142-149.
41. Bussel JB, McFarland JG, Berkowitz RL. Antenatal management of fetal alloimmune thrombocytopenia. Transfus Med Rev. 1990;4:149-162.
42. Williamson LM. Screening programmes for fetomaternal alloimmune thrombocytopenia. Vox Sang. 1998;74:385-389.
43. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-la antigen, antibody and alloimmune thrombocytopenia. Vox Sang. 2003;85:326-327.
44. Kaplan C. Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev. 2002;16:69-72.
45. Hennekens CH, Buring JE. Epidemiology in Medicine. Philadelphia: Lippincott Williams & Wilkins; 1987.
46. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol. 1996;13:423-431.
47. Curtis BR, Bussel JB, Manco-Johnson MJ, et al. Fetal cases and neonatal alloimmune thrombocytopenia in pregnancies involving in vitro fertilization: a report of four cases. Am J Obstet Gynecol. 2005;192:543-547.
48. Kim HO, Jin Y, Kickler TS, et al. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion. 1995;35:863-867.
49. Cardone JDB, Chiba AK, Boturao-Neto E, et al. Gene frequencies of the HPA-15 (Gov) platelet alloantigen system in Brazilians. Transfus Med. 2004;14:433-437.